Skip to main content
. 2021 Sep 27;13(19):4829. doi: 10.3390/cancers13194829

Figure 1.

Figure 1

Prostate cancer proteomics. A typical outline of current studies involving patient tumor tissue samples and prostate cancer (PC) cell lines which are subjected to protein extraction and analyzed by quantitative mass spectrometry (LC-MS/MS) either for full proteomes or specific sub-proteomes, depending on sample preparation. Typically, datasets and identified proteins of interest are validated using alternative methods and additional samples.